Petco Health and Wellness (WOOF) Financials

$3.63 +0.05 (+1.40%)

Closing price 05/30/2025 04:00 PM Eastern

Extended Trading

$3.66 +0.04 (+0.96%)

As of 05/30/2025 07:43 PM Eastern

Annual Income Statements for Petco Health and Wellness

This table shows Petco Health and Wellness' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019
Period end date	2/1/2025	2/3/2024	1/28/2023	1/29/2022	1/30/2021	2/1/2020
Net Income / (Loss) Attributable to Common Shareholders	-102	-1,280	91	164	-26	-96
Consolidated Net Income / (Loss)	-102	-1,280	90	160	-32	-104
Net Income / (Loss) Continuing Operations	-102	-1,280	90	160	-32	-104
Total Pre-Tax Income	-128	-1,324	112	202	-42	-142
Total Operating Income	7.05	-1,180	226	266	194	111
Total Gross Profit	2,324	2,354	2,427	2,427	2,107	1,907
Total Revenue	6,116	6,255	6,036	5,807	4,920	4,435
Operating Revenue	6,116	6,255	6,036	5,807	4,920	4,435
Total Cost of Revenue	3,792	3,901	3,609	3,381	2,813	2,528
Operating Cost of Revenue	3,792	3,901	3,609	3,381	2,813	2,528
Total Operating Expenses	2,317	3,534	2,202	2,161	1,912	1,796
Selling, General & Admin Expense	2,317	2,312	2,202	2,161	1,912	1,777
Impairment Charge	0.00	1,223	0.00	0.00	0.00	19
Total Other Income / (Expense), net	-135	-144	-113	-64	-236	-253
Interest Expense	144	152	102	98	237	253
Interest & Investment Income	3.71	3.41	1.03	0.06	0.65	0.34
Other Income / (Expense), net	4.80	4.73	-13	34	0.00	0.00
Income Tax Expense	-7.48	-28	35	53	-3.34	-36
Other Gains / (Losses), net	19	16	13	11	6.48	2.44
Net Income / (Loss) Attributable to Noncontrolling Interest	0.00	0.00	-0.89	-4.61	-5.25	-8.11
Basic Earnings per Share	($0.37)	($4.78)	$0.34	$0.62	($0.13)	($0.46)
Weighted Average Basic Shares Outstanding	273.41M	267.55M	265.52M	264.26M	210.68M	208.93M
Diluted Earnings per Share	($0.37)	($4.78)	$0.34	$0.62	($0.13)	($0.46)
Weighted Average Diluted Shares Outstanding	273.41M	267.55M	265.95M	265.34M	210.68M	208.93M
Weighted Average Basic & Diluted Shares Outstanding	315.13M	307.37M	304.55M	303.03M	-	-

This table shows Petco Health and Wellness' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	2/1/2025	11/2/2024	8/3/2024	5/4/2024	2/3/2024	10/28/2023	7/29/2023	4/29/2023	1/28/2023	10/29/2022
Net Income / (Loss) Attributable to Common Shareholders	-14	-17	-25	-46	-23	-1,241	-15	-1.89	33	20
Consolidated Net Income / (Loss)	-14	-17	-25	-46	-23	-1,241	-15	-1.89	33	20
Net Income / (Loss) Continuing Operations	-14	-17	-25	-46	-23	-1,241	-15	-1.89	33	20
Total Pre-Tax Income	-16	-22	-34	-56	-39	-1,268	-11	-6.03	42	21
Total Operating Income	17	3.98	2.47	-17	0.17	-1,232	24	28	78	48
Total Gross Profit	589	576	581	579	606	550	593	604	627	598
Total Revenue	1,552	1,511	1,524	1,529	1,674	1,494	1,531	1,556	1,578	1,501
Operating Revenue	1,552	1,511	1,524	1,529	1,674	1,494	1,531	1,556	1,578	1,501
Total Cost of Revenue	963	936	943	950	1,068	944	938	951	951	904
Operating Cost of Revenue	963	936	943	950	1,068	944	938	951	951	904
Total Operating Expenses	572	572	578	595	606	1,782	569	577	550	550
Selling, General & Admin Expense	572	572	578	595	606	560	569	577	550	550
Total Other Income / (Expense), net	-39	-26	-36	-34	-42	-35	-35	-31	-35	-27
Interest Expense	34	36	37	37	40	37	38	38	33	27
Interest & Investment Income	-3.61	1.35	0.67	5.30	-2.81	1.14	0.76	4.31	0.75	0.13
Other Income / (Expense), net	-1.00	8.47	0.00	-2.67	-	0.11	1.80	2.82	-3.30	0.58
Income Tax Expense	2.50	-0.86	-4.65	-4.48	-10	-23	6.73	-1.01	15	4.16
Basic Earnings per Share	($0.05)	($0.06)	($0.09)	($0.17)	($0.09)	($4.63)	($0.05)	($0.01)	$0.13	$0.07
Weighted Average Basic Shares Outstanding	273.41M	274.50M	273.07M	269.77M	267.55M	267.85M	267.16K	266.49K	265.52M	265.69M
Diluted Earnings per Share	($0.05)	($0.06)	($0.09)	($0.17)	($0.09)	($4.63)	($0.05)	($0.01)	$0.13	$0.07
Weighted Average Diluted Shares Outstanding	273.41M	274.50M	273.07M	269.77M	267.55M	267.85M	267.16K	266.49K	265.95M	265.94M
Weighted Average Basic & Diluted Shares Outstanding	315.13M	313.45M	312.15M	310.78M	307.37M	306.28M	305.56M	304.80M	304.55M	303.71M

This table details how cash moves in and out of Petco Health and Wellness' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019
Period end date	2/1/2025	2/3/2024	1/28/2023	1/29/2022	1/30/2021	2/1/2020
Net Change in Cash & Equivalents	45	-77	-8.16	102	-35	-32
Net Cash From Operating Activities	178	216	346	358	269	110
Net Cash From Continuing Operating Activities	178	216	346	358	269	110
Net Income / (Loss) Continuing Operations	-102	-1,280	90	160	-32	-104
Consolidated Net Income / (Loss)	-102	-1,280	90	160	-32	-104
Depreciation Expense	200	201	194	172	175	174
Amortization Expense	4.90	4.97	4.94	5.80	24	23
Non-Cash Adjustments To Reconcile Net Income	447	1,716	485	458	481	483
Changes in Operating Assets and Liabilities, net	-372	-426	-428	-438	-379	-465
Net Cash From Investing Activities	-124	-207	-320	-237	-157	-139
Net Cash From Continuing Investing Activities	-124	-207	-320	-237	-157	-139
Purchase of Property, Plant & Equipment	-128	-226	-278	-239	-160	-157
Acquisitions	-0.63	-6.73	-45	-4.33	0.00	-3.26
Purchase of Investments	-0.46	0.00	0.00	0.00	-1.00	-0.59
Sale of Property, Plant & Equipment	1.37	0.00	2.34	0.23	3.30	0.00
Sale and/or Maturity of Investments	1.00	25	0.00	6.14	0.07	0.00
Other Investing Activities, net	2.81	0.00	0.00	0.00	0.00	21
Net Cash From Financing Activities	-8.75	-85	-34	-19	-147	-3.07
Net Cash From Continuing Financing Activities	-8.75	-85	-34	-19	-147	-3.07
Repayment of Debt	-204	-348	-140	-1,716	-1,555	-1,293
Issuance of Debt	201	273	123	1,700	476	1,297
Issuance of Common Equity	2.50	0.00	0.00	0.00	936	0.24
Other Financing Activities, net	-8.23	-10	-17	0.59	-3.65	-7.01
Cash Interest Paid	139	143	91	66	179	219
Cash Income Taxes Paid	35	32	14	16	2.39	15

This table details how cash moves in and out of Petco Health and Wellness' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	2/1/2025	11/2/2024	8/3/2024	5/4/2024	2/3/2024	10/28/2023	7/29/2023	4/29/2023	1/28/2023	10/29/2022
Net Change in Cash & Equivalents	61	-13	43	-46	-5.59	-34	25	-62	62	24
Net Cash From Operating Activities	96	21	69	-8.41	47	34	97	38	137	109
Net Cash From Continuing Operating Activities	96	21	69	-8.41	47	34	97	38	137	109
Net Income / (Loss) Continuing Operations	-14	-17	-25	-46	-23	-1,241	-15	-1.89	33	20
Consolidated Net Income / (Loss)	-14	-17	-25	-46	-23	-1,241	-15	-1.89	33	20
Depreciation Expense	50	50	50	50	52	51	49	49	50	48
Amortization Expense	1.24	1.23	1.22	1.22	1.31	1.21	1.21	1.24	1.25	1.24
Non-Cash Adjustments To Reconcile Net Income	109	103	114	121	123	1,343	126	124	124	119
Changes in Operating Assets and Liabilities, net	-50	-117	-71	-134	-107	-119	-65	-134	-72	-79
Net Cash From Investing Activities	-34	-31	-26	-32	-51	-50	-43	-63	-68	-81
Net Cash From Continuing Investing Activities	-34	-31	-26	-32	-51	-50	-43	-63	-68	-81
Purchase of Property, Plant & Equipment	-37	-31	-27	-33	-49	-63	-52	-62	-66	-76
Acquisitions	-0.17	-0.21	-0.16	-0.10	-2.23	-2.46	-1.32	-0.73	-1.89	-4.86
Sale of Property, Plant & Equipment	0.12	0.23	-	-	-	-	-	-	0.21	-
Other Investing Activities, net	2.60	-	-	-	-	-	-	-	-	-
Net Cash From Financing Activities	-0.95	-1.91	-0.27	-5.63	-1.31	-18	-29	-37	-6.81	-4.70
Net Cash From Continuing Financing Activities	-0.95	-1.91	-0.27	-5.63	-1.31	-18	-29	-37	-6.81	-4.70
Other Financing Activities, net	-0.95	-1.91	-1.86	-3.50	-1.31	-3.27	-2.31	-3.46	0.91	-1.33
Cash Interest Paid	34	36	35	34	36	35	35	37	30	25
Cash Income Taxes Paid	10	9.07	14	1.28	0.93	3.84	18	8.93	4.85	4.14

This table presents Petco Health and Wellness' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020
Period end date	2/1/2025	2/3/2024	1/28/2023	1/29/2022	1/30/2021
Total Assets	5,194	5,363	6,613	5,473	6,076
Total Current Assets	974	952	1,016	1,071	778
Cash & Equivalents	166	125	202	212	111
Accounts Receivable	40	44	50	56	42
Inventories, net	653	685	652	675	539
Prepaid Expenses	54	59	51	42	40
Other Current Assets	61	39	61	86	46
Plant, Property, & Equipment, net	725	816	803	727	628
Total Noncurrent Assets	3,495	3,595	4,794	3,675	4,671
Goodwill	980	980	2,194	2,184	2,179
Intangible Assets	1,025	1,025	1,025	-	1,025
Other Noncurrent Operating Assets	1,490	1,590	1,575	1,491	1,466
Total Liabilities & Shareholders' Equity	5,194	5,363	6,613	6,498	6,076
Total Liabilities	4,081	4,179	4,231	4,242	4,020
Total Current Liabilities	1,139	1,113	1,021	1,053	875
Short-Term Debt	5.35	16	23	-	2.20
Accounts Payable	493	485	381	404	339
Accrued Expenses	177	200	218	211	146
Current Employee Benefit Liabilities	157	101	90	151	129
Other Current Liabilities	306	311	310	266	258
Total Noncurrent Liabilities	2,942	3,066	3,210	3,189	3,145
Long-Term Debt	1,578	1,576	1,628	1,640	1,646
Noncurrent Deferred & Payable Income Tax Liabilities	218	252	303	318	281
Other Noncurrent Operating Liabilities	1,146	1,238	1,279	1,230	1,218
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,114	1,184	2,381	2,256	2,055
Total Preferred & Common Equity	1,114	1,184	2,381	2,274	2,069
Preferred Stock	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,114	1,184	2,381	2,274	2,069
Common Stock	2,281	2,230	2,153	2,134	2,092
Retained Earnings	-1,149	-1,047	233	142	-22
Accumulated Other Comprehensive Income / (Loss)	-18	1.82	-4.10	-2.24	-1.28

This table presents Petco Health and Wellness' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	11/2/2024	8/3/2024	5/4/2024	10/28/2023	7/29/2023	4/29/2023	10/29/2022
Total Assets	5,211	5,277	5,259	5,427	6,662	6,572	6,577
Total Current Assets	932	942	904	1,008	1,025	977	1,019
Cash & Equivalents	117	128	90	140	173	149	149
Accounts Receivable	40	47	42	50	66	45	46
Inventories, net	690	672	681	730	675	668	723
Prepaid Expenses	47	60	65	47	55	53	44
Other Current Assets	38	35	26	41	55	61	57
Plant, Property, & Equipment, net	740	760	779	828	820	812	792
Plant, Property & Equipment, gross	2,234	2,207	2,177	2,143	2,090	2,042	1,938
Accumulated Depreciation	1,494	1,447	1,399	1,315	1,270	1,229	1,146
Total Noncurrent Assets	3,540	3,575	3,576	3,591	4,817	4,783	4,766
Goodwill	980	980	980	976	2,197	2,194	2,192
Intangible Assets	1,025	1,025	1,025	1,025	1,025	1,025	1,025
Other Noncurrent Operating Assets	1,535	1,570	1,571	1,590	1,596	1,564	1,549
Total Liabilities & Shareholders' Equity	5,211	5,277	5,259	5,427	6,662	6,572	6,577
Total Liabilities	4,089	4,145	4,097	4,234	4,247	4,171	4,249
Total Current Liabilities	1,114	1,118	1,069	1,115	1,075	997	1,057
Short-Term Debt	5.29	5.10	3.68	5.08	5.08	5.91	23
Accounts Payable	448	474	465	487	478	394	385
Accrued Expenses	191	197	198	216	220	207	220
Current Employee Benefit Liabilities	129	135	95	101	91	109	125
Other Current Liabilities	340	307	308	306	281	282	305
Total Noncurrent Liabilities	2,975	3,027	3,027	3,119	3,173	3,174	3,192
Long-Term Debt	1,577	1,576	1,574	1,575	1,589	1,612	1,631
Noncurrent Deferred & Payable Income Tax Liabilities	211	220	241	271	294	298	298
Other Noncurrent Operating Liabilities	1,187	1,232	1,212	1,273	1,290	1,265	1,262
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,123	1,131	1,162	1,193	2,415	2,401	2,328
Total Preferred & Common Equity	1,123	1,131	1,162	1,193	2,415	2,401	2,328
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,123	1,131	1,162	1,193	2,415	2,401	2,328
Common Stock	2,271	2,261	2,247	2,213	2,197	2,174	2,132
Retained Earnings	-1,135	-1,119	-1,094	-1,025	216	231	200
Accumulated Other Comprehensive Income / (Loss)	-13	-11	9.01	4.54	1.79	-3.59	-4.52

This table displays calculated financial ratios and metrics derived from Petco Health and Wellness' official financial filings.

Metric	2024	2023	2022	2021	2020	2019
Period end date	2/1/2025	2/3/2024	1/28/2023	1/29/2022	1/30/2021	2/1/2020
Growth Metrics	-	-	-	-	-	-
Revenue Growth	-2.22%	3.63%	3.94%	18.03%	10.95%	0.00%
EBITDA Growth	122.32%	-335.59%	-14.02%	21.68%	27.93%	0.00%
EBIT Growth	101.01%	-652.20%	-29.17%	54.59%	75.79%	0.00%
NOPAT Growth	100.60%	-634.59%	-21.06%	43.85%	75.79%	0.00%
Net Income Growth	92.05%	-1,523.88%	-43.74%	603.54%	69.48%	0.00%
EPS Growth	92.26%	-1,505.88%	-45.16%	576.92%	71.74%	0.00%
Operating Cash Flow Growth	-17.64%	-37.65%	-3.41%	33.36%	143.45%	0.00%
Free Cash Flow Firm Growth	-64.67%	135.51%	-189.88%	132.02%	0.00%	0.00%
Invested Capital Growth	-4.52%	-30.79%	42.86%	-25.36%	0.00%	0.00%
Revenue Q/Q Growth	-1.96%	1.57%	1.06%	-13.89%	0.00%	0.00%
EBITDA Q/Q Growth	7.06%	-8.03%	-3.41%	10.79%	0.00%	0.00%
EBIT Q/Q Growth	371.13%	-6.73%	-7.80%	20.16%	0.00%	0.00%
NOPAT Q/Q Growth	169.32%	-7.02%	-5.21%	15.14%	0.00%	0.00%
Net Income Q/Q Growth	7.90%	-4.52%	6.45%	1.93%	0.00%	0.00%
EPS Q/Q Growth	9.76%	-4.82%	6.25%	31.91%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	38.05%	-29.33%	23.91%	0.74%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	231.68%	-17.46%	-13,317.90%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	-2.20%	0.69%	-0.06%	-26.79%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-
Gross Margin	38.00%	37.63%	40.21%	41.79%	42.82%	42.99%
EBITDA Margin	3.54%	-15.50%	6.82%	8.24%	8.00%	6.94%
Operating Margin	0.12%	-18.87%	3.74%	4.58%	3.95%	2.49%
EBIT Margin	0.19%	-18.79%	3.53%	5.18%	3.95%	2.49%
Profit (Net Income) Margin	-1.66%	-20.47%	1.49%	2.75%	-0.65%	-2.34%
Tax Burden Percent	79.56%	96.69%	80.08%	78.96%	76.37%	73.19%
Interest Burden Percent	-1,079.79%	112.63%	52.74%	67.34%	-21.37%	-128.47%
Effective Tax Rate	0.00%	0.00%	31.48%	26.42%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.19%	-25.49%	4.75%	6.24%	7.58%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-7.21%	-56.63%	-2.15%	2.58%	-14.26%	0.00%
Return on Net Nonoperating Assets (RNNOA)	-9.05%	-46.31%	-0.87%	1.17%	-10.67%	0.00%
Return on Equity (ROE)	-8.86%	-71.80%	3.88%	7.41%	-3.09%	0.00%
Cash Return on Invested Capital (CROIC)	4.82%	10.90%	-30.55%	35.28%	-192.42%	0.00%
Operating Return on Assets (OROA)	0.22%	-19.63%	3.52%	5.21%	3.20%	0.00%
Return on Assets (ROA)	-1.93%	-21.38%	1.49%	2.77%	-0.52%	0.00%
Return on Common Equity (ROCE)	-8.86%	-71.80%	3.89%	7.47%	-3.11%	0.00%
Return on Equity Simple (ROE_SIMPLE)	-9.14%	-108.09%	3.78%	7.03%	-1.53%	0.00%
Net Operating Profit after Tax (NOPAT)	4.94	-826	155	196	136	77
NOPAT Margin	0.08%	-13.21%	2.56%	3.37%	2.77%	1.75%
Net Nonoperating Expense Percent (NNEP)	7.40%	31.14%	6.90%	3.67%	21.84%	0.00%
Return On Investment Capital (ROIC_SIMPLE)	0.18%	-29.76%	3.83%	-	-	-
Cost of Revenue to Revenue	62.00%	62.37%	59.79%	58.21%	57.18%	57.01%
SG&A Expenses to Revenue	37.89%	36.95%	36.47%	37.20%	38.87%	40.07%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	37.89%	56.50%	36.47%	37.20%	38.87%	40.50%
Earnings before Interest and Taxes (EBIT)	12	-1,176	213	301	194	111
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	216	-970	412	479	393	308
Valuation Ratios	-	-	-	-	-	-
Price to Book Value (P/BV)	0.96	0.64	1.50	2.43	0.60	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	61.43	0.00	0.00
Price to Revenue (P/Rev)	0.18	0.12	0.59	0.95	0.25	0.19
Price to Earnings (P/E)	0.00	0.00	39.27	33.64	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	2.55%	2.97%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.98	0.84	1.31	2.59	0.77	0.00
Enterprise Value to Revenue (EV/Rev)	0.41	0.36	0.83	1.20	0.56	0.00
Enterprise Value to EBITDA (EV/EBITDA)	11.50	0.00	12.18	14.50	7.05	0.00
Enterprise Value to EBIT (EV/EBIT)	210.08	0.00	23.56	23.09	14.26	0.00
Enterprise Value to NOPAT (EV/NOPAT)	504.42	0.00	32.45	35.45	20.37	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	14.01	10.32	14.49	19.38	10.32	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	19.95	6.30	0.00	6.27	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-
Debt to Equity	1.42	1.34	0.69	0.73	0.80	0.00
Long-Term Debt to Equity	1.42	1.33	0.68	0.73	0.80	0.00
Financial Leverage	1.26	0.82	0.40	0.46	0.75	0.00
Leverage Ratio	4.59	3.36	2.61	2.68	2.96	0.00
Compound Leverage Factor	-49.61	3.78	1.37	1.80	-0.63	0.00
Debt to Total Capital	58.71%	57.34%	40.94%	42.10%	44.51%	0.00%
Short-Term Debt to Total Capital	0.20%	0.57%	0.57%	0.00%	0.06%	0.00%
Long-Term Debt to Total Capital	58.51%	56.77%	40.38%	42.10%	44.45%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	-0.47%	-0.37%	0.00%
Common Equity to Total Capital	41.29%	42.66%	59.06%	58.36%	55.86%	0.00%
Debt to EBITDA	7.31	-1.64	4.01	3.43	4.19	0.00
Net Debt to EBITDA	6.55	-1.51	3.52	2.98	3.91	0.00
Long-Term Debt to EBITDA	7.29	-1.63	3.96	3.43	4.18	0.00
Debt to NOPAT	320.81	-1.93	10.68	8.38	12.11	0.00
Net Debt to NOPAT	287.23	-1.78	9.38	7.30	11.29	0.00
Long-Term Debt to NOPAT	319.73	-1.91	10.54	8.38	12.10	0.00
Altman Z-Score	0.99	0.24	1.57	2.06	1.08	0.00
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	-0.39%	-0.74%	-0.66%	0.00%
Liquidity Ratios	-	-	-	-	-	-
Current Ratio	0.85	0.86	0.99	1.02	0.89	0.00
Quick Ratio	0.18	0.15	0.25	0.25	0.18	0.00
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	125	353	-995	1,107	-3,456	0.00
Operating Cash Flow to CapEx	140.32%	95.62%	125.51%	149.95%	171.90%	70.32%
Free Cash Flow to Firm to Interest Expense	0.87	2.33	-9.79	11.27	-14.61	0.00
Operating Cash Flow to Interest Expense	1.24	1.42	3.40	3.65	1.14	0.44
Operating Cash Flow Less CapEx to Interest Expense	0.36	-0.07	0.69	1.21	0.47	-0.18
Efficiency Ratios	-	-	-	-	-	-
Asset Turnover	1.16	1.04	1.00	1.01	0.81	0.00
Accounts Receivable Turnover	144.27	133.16	114.75	119.19	117.63	0.00
Inventory Turnover	5.67	5.84	5.44	5.57	5.22	0.00
Fixed Asset Turnover	7.93	7.72	7.89	8.57	7.84	0.00
Accounts Payable Turnover	7.75	9.01	9.19	9.09	8.29	0.00
Days Sales Outstanding (DSO)	2.53	2.74	3.18	3.06	3.10	0.00
Days Inventory Outstanding (DIO)	64.39	62.54	67.13	65.53	69.88	0.00
Days Payable Outstanding (DPO)	47.07	40.53	39.71	40.14	44.04	0.00
Cash Conversion Cycle (CCC)	19.85	24.75	30.61	28.45	28.94	0.00
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	2,531	2,651	3,831	2,681	3,592	0.00
Invested Capital Turnover	2.36	1.93	1.85	1.85	2.74	0.00
Increase / (Decrease) in Invested Capital	-120	-1,180	1,149	-911	3,592	0.00
Enterprise Value (EV)	2,490	2,226	5,015	6,941	2,773	0.00
Market Capitalization	1,072	760	3,566	5,530	1,249	864
Book Value per Share	$3.55	$3.87	$7.84	$7.52	$9.82	$0.00
Tangible Book Value per Share	($2.84)	($2.68)	($2.76)	$0.30	($5.39)	$0.00
Total Capital	2,697	2,777	4,033	3,896	3,704	0.00
Total Debt	1,583	1,592	1,651	1,640	1,648	0.00
Total Long-Term Debt	1,578	1,576	1,628	1,640	1,646	0.00
Net Debt	1,418	1,467	1,449	1,429	1,537	0.00
Capital Expenditures (CapEx)	127	226	276	239	156	157
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-326	-271	-184	-194	-207	0.00
Debt-free Net Working Capital (DFNWC)	-160	-145	18	18	-96	0.00
Net Working Capital (NWC)	-166	-161	-5.26	18	-98	0.00
Net Nonoperating Expense (NNE)	107	454	65	36	168	181
Net Nonoperating Obligations (NNO)	1,418	1,467	1,449	426	1,537	0.00
Total Depreciation and Amortization (D&A)	205	206	199	178	199	197
Debt-free, Cash-free Net Working Capital to Revenue	-5.33%	-4.33%	-3.05%	-3.34%	-4.21%	0.00%
Debt-free Net Working Capital to Revenue	-2.62%	-2.33%	0.29%	0.30%	-1.94%	0.00%
Net Working Capital to Revenue	-2.71%	-2.58%	-0.09%	0.30%	-1.99%	0.00%
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.37)	($4.78)	$0.34	$0.62	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	273.41M	267.55M	265.52M	264.26M	0.00	0.00
Adjusted Diluted Earnings per Share	($0.37)	($4.78)	$0.34	$0.62	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	273.41M	267.55M	265.95M	265.34M	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	315.13M	307.37M	304.55M	303.03M	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	4.94	30	155	196	136	91
Normalized NOPAT Margin	0.08%	0.47%	2.56%	3.37%	2.77%	2.05%
Pre Tax Income Margin	-2.09%	-21.17%	1.86%	3.49%	-0.84%	-3.20%
Debt Service Ratios	-	-	-	-	-	-
EBIT to Interest Expense	0.08	-7.74	2.09	3.06	0.82	0.44
NOPAT to Interest Expense	0.03	-5.44	1.52	1.99	0.58	0.31
EBIT Less CapEx to Interest Expense	-0.80	-9.23	-0.62	0.63	0.16	-0.18
NOPAT Less CapEx to Interest Expense	-0.85	-6.93	-1.19	-0.44	-0.09	-0.31
Payout Ratios	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	2.41%	-0.33%	0.00%

This table displays calculated financial ratios and metrics derived from Petco Health and Wellness' official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	2/1/2025	11/2/2024	8/3/2024	5/4/2024	2/3/2024	10/28/2023	7/29/2023	4/29/2023	1/28/2023	10/29/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-7.31%	1.16%	-0.46%	-1.72%	6.12%	-0.47%	3.37%	5.41%	4.20%	4.02%
EBITDA Growth	26.58%	105.40%	-29.46%	-61.25%	-57.32%	-1,305.47%	-15.49%	-17.79%	-3.96%	-22.13%
EBIT Growth	9,772.29%	101.01%	-90.45%	-163.89%	-99.78%	-2,633.41%	-35.01%	-39.43%	-10.43%	-40.49%
NOPAT Growth	10,374.70%	100.32%	-89.73%	-160.77%	-99.77%	-2,326.67%	-46.80%	-42.53%	-13.93%	-19.44%
Net Income Growth	38.71%	98.66%	-69.95%	-2,356.82%	-168.97%	-6,330.61%	-208.55%	-107.95%	19.95%	-61.33%
EPS Growth	44.44%	98.70%	-80.00%	-1,600.00%	-169.23%	-6,714.29%	-200.00%	-111.11%	18.18%	-65.00%
Operating Cash Flow Growth	104.14%	-39.81%	-28.20%	-122.35%	-65.56%	-68.52%	126.96%	-34.54%	95.70%	27.12%
Free Cash Flow Firm Growth	-88.81%	-85.92%	11.07%	1,373.89%	207.38%	356.29%	187.29%	38.60%	-213.26%	96.36%
Invested Capital Growth	-4.52%	-1.70%	-32.61%	-31.51%	-30.79%	-31.31%	-22.46%	3.04%	42.86%	4.65%
Revenue Q/Q Growth	2.69%	-0.81%	-0.35%	-8.68%	12.07%	-2.39%	-1.62%	-1.40%	5.11%	1.38%
EBITDA Q/Q Growth	6.52%	19.43%	70.30%	-41.57%	104.55%	-1,658.88%	-6.46%	-35.64%	28.44%	9.28%
EBIT Q/Q Growth	31.72%	404.13%	112.69%	-11,815.06%	100.01%	-4,869.36%	-15.13%	-59.02%	52.71%	22.35%
NOPAT Q/Q Growth	337.21%	61.14%	114.71%	-10,209.64%	100.01%	-5,225.99%	-12.96%	-61.93%	31.08%	22.47%
Net Income Q/Q Growth	17.01%	32.83%	46.60%	-105.90%	98.18%	-8,397.45%	-671.99%	-105.78%	64.32%	48.04%
EPS Q/Q Growth	16.67%	33.33%	47.06%	-88.89%	98.06%	-9,160.00%	-400.00%	-107.69%	85.71%	40.00%
Operating Cash Flow Q/Q Growth	363.20%	-70.13%	924.46%	-117.89%	36.57%	-64.36%	156.60%	-72.42%	24.84%	156.94%
Free Cash Flow Firm Q/Q Growth	177.79%	-96.20%	3.72%	2.37%	249.42%	-70.06%	1,289.58%	91.37%	-733.97%	89.80%
Invested Capital Q/Q Growth	-2.20%	0.14%	-2.50%	-0.02%	0.69%	-31.35%	-0.90%	1.03%	-0.06%	-22.50%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	37.96%	38.09%	38.11%	37.84%	36.21%	36.81%	38.74%	38.85%	39.75%	39.81%
EBITDA Margin	4.38%	4.22%	3.50%	2.05%	3.21%	-78.98%	4.95%	5.20%	7.97%	6.52%
Operating Margin	1.12%	0.26%	0.16%	-1.10%	0.01%	-82.46%	1.57%	1.78%	4.92%	3.20%
EBIT Margin	1.06%	0.82%	0.16%	-1.27%	0.01%	-82.46%	1.69%	1.96%	4.71%	3.24%
Profit (Net Income) Margin	-0.89%	-1.10%	-1.63%	-3.04%	-1.35%	-83.07%	-0.95%	-0.12%	2.07%	1.33%
Tax Burden Percent	84.14%	75.76%	73.74%	83.23%	57.64%	97.91%	130.39%	31.38%	77.70%	92.85%
Interest Burden Percent	-100.35%	-176.89%	-1,364.06%	287.17%	-23,593.98%	102.89%	-43.36%	-19.81%	56.72%	44.12%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	34.54%	19.40%
Return on Invested Capital (ROIC)	1.85%	0.44%	0.22%	-1.47%	0.01%	-109.96%	1.54%	1.99%	5.97%	4.11%
ROIC Less NNEP Spread (ROIC-NNEP)	0.05%	-0.90%	-1.63%	-3.82%	-1.54%	-135.67%	0.01%	0.55%	4.04%	2.83%
Return on Net Nonoperating Assets (RNNOA)	0.06%	-1.13%	-1.32%	-3.17%	-1.26%	-113.50%	0.00%	0.34%	1.63%	1.84%
Return on Equity (ROE)	1.91%	-0.69%	-1.10%	-4.64%	-1.25%	-223.46%	1.55%	2.34%	7.60%	5.95%
Cash Return on Invested Capital (CROIC)	4.82%	1.44%	11.79%	11.10%	10.90%	13.24%	27.21%	0.62%	-30.55%	-0.20%
Operating Return on Assets (OROA)	1.22%	0.97%	0.17%	-1.34%	0.01%	-84.61%	1.58%	1.83%	4.70%	2.97%
Return on Assets (ROA)	-1.03%	-1.29%	-1.70%	-3.20%	-1.41%	-85.24%	-0.89%	-0.11%	2.07%	1.21%
Return on Common Equity (ROCE)	1.91%	-0.69%	-1.10%	-4.64%	-1.25%	-223.46%	1.55%	2.35%	7.63%	5.97%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-9.85%	-117.99%	-113.98%	0.00%	-102.69%	1.50%	2.67%	0.00%	3.63%
Net Operating Profit after Tax (NOPAT)	12	2.78	1.73	-12	0.12	-862	17	19	51	39
NOPAT Margin	0.78%	0.18%	0.11%	-0.77%	0.01%	-57.72%	1.10%	1.24%	3.22%	2.58%
Net Nonoperating Expense Percent (NNEP)	1.80%	1.34%	1.85%	2.35%	1.56%	25.71%	1.54%	1.45%	1.92%	1.28%
Return On Investment Capital (ROIC_SIMPLE)	0.45%	-	-	-	0.00%	-	-	-	1.26%	-
Cost of Revenue to Revenue	62.04%	61.91%	61.89%	62.16%	63.79%	63.19%	61.26%	61.15%	60.25%	60.19%
SG&A Expenses to Revenue	36.84%	37.83%	37.95%	38.94%	36.20%	37.45%	37.17%	37.08%	34.84%	36.61%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	36.84%	37.83%	37.95%	38.94%	36.20%	119.27%	37.17%	37.08%	34.84%	36.61%
Earnings before Interest and Taxes (EBIT)	16	12	2.47	-19	0.17	-1,232	26	30	74	49
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	68	64	53	31	54	-1,180	76	81	126	98
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.96	1.25	0.80	0.41	0.64	0.84	1.05	1.26	1.50	1.38
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.18	0.22	0.14	0.08	0.12	0.16	0.41	0.50	0.59	0.54
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	69.89	47.24	39.27	37.02
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.43%	2.12%	2.55%	2.70%
Enterprise Value to Invested Capital (EV/IC)	0.98	1.11	0.91	0.74	0.84	0.93	1.03	1.16	1.31	1.23
Enterprise Value to Revenue (EV/Rev)	0.41	0.46	0.38	0.32	0.36	0.40	0.64	0.74	0.83	0.79
Enterprise Value to EBITDA (EV/EBITDA)	11.50	14.18	0.00	0.00	0.00	0.00	10.38	11.42	12.18	11.09
Enterprise Value to EBIT (EV/EBIT)	210.08	0.00	0.00	0.00	0.00	0.00	22.03	23.32	23.56	20.48
Enterprise Value to NOPAT (EV/NOPAT)	504.42	0.00	0.00	0.00	0.00	0.00	47.10	32.67	32.45	29.00
Enterprise Value to Operating Cash Flow (EV/OCF)	14.01	22.28	16.53	11.58	10.32	8.01	10.38	13.80	14.49	16.93
Enterprise Value to Free Cash Flow (EV/FCFF)	19.95	76.19	6.22	5.43	6.30	5.71	3.30	190.05	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.42	1.41	1.40	1.36	1.34	1.32	0.66	0.67	0.69	0.71
Long-Term Debt to Equity	1.42	1.40	1.39	1.35	1.33	1.32	0.66	0.67	0.68	0.70
Financial Leverage	1.26	1.25	0.81	0.83	0.82	0.84	0.87	0.63	0.40	0.65
Leverage Ratio	4.59	4.59	3.37	3.32	3.36	3.41	2.81	2.79	2.61	2.87
Compound Leverage Factor	-4.61	-8.13	-45.92	9.53	-792.40	3.51	-1.22	-0.55	1.48	1.27
Debt to Total Capital	58.71%	58.49%	58.28%	57.59%	57.34%	56.98%	39.76%	40.26%	40.94%	41.54%
Short-Term Debt to Total Capital	0.20%	0.20%	0.19%	0.13%	0.57%	0.18%	0.13%	0.15%	0.57%	0.57%
Long-Term Debt to Total Capital	58.51%	58.29%	58.09%	57.45%	56.77%	56.80%	39.63%	40.11%	40.38%	40.97%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	41.29%	41.51%	41.72%	42.41%	42.66%	43.02%	60.24%	59.74%	59.06%	58.46%
Debt to EBITDA	7.31	7.82	-1.52	-1.55	-1.64	-1.76	4.19	4.10	4.01	3.88
Net Debt to EBITDA	6.55	7.25	-1.39	-1.46	-1.51	-1.60	3.74	3.73	3.52	3.53
Long-Term Debt to EBITDA	7.29	7.80	-1.51	-1.54	-1.63	-1.75	4.18	4.09	3.96	3.83
Debt to NOPAT	320.81	-222.22	-1.81	-1.84	-1.93	-2.05	19.01	11.74	10.68	10.14
Net Debt to NOPAT	287.23	-205.83	-1.67	-1.74	-1.78	-1.87	16.95	10.66	9.38	9.23
Long-Term Debt to NOPAT	319.73	-221.48	-1.81	-1.84	-1.91	-2.04	18.95	11.70	10.54	10.01
Altman Z-Score	1.00	1.06	0.97	0.91	0.97	0.24	1.33	1.43	1.50	1.42
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.41%	-0.39%	-0.36%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.85	0.84	0.84	0.85	0.86	0.90	0.95	0.98	0.99	0.96
Quick Ratio	0.18	0.14	0.16	0.12	0.15	0.17	0.22	0.20	0.25	0.18
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	132	48	1,252	1,208	1,180	338	1,128	-95	-1,099	-132
Operating Cash Flow to CapEx	260.62%	67.33%	253.29%	-25.78%	95.84%	55.08%	185.89%	60.68%	207.71%	144.13%
Free Cash Flow to Firm to Interest Expense	3.87	1.33	34.03	32.80	29.75	9.19	29.83	-2.52	-33.41	-4.82
Operating Cash Flow to Interest Expense	2.81	0.58	1.88	-0.23	1.19	0.94	2.56	1.00	4.15	4.01
Operating Cash Flow Less CapEx to Interest Expense	1.73	-0.28	1.14	-1.12	-0.05	-0.76	1.18	-0.65	2.15	1.23
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.16	1.17	1.04	1.05	1.04	1.03	0.93	0.94	1.00	0.92
Accounts Receivable Turnover	144.27	137.70	109.83	142.37	133.16	127.48	111.08	139.58	114.75	129.94
Inventory Turnover	5.67	5.49	5.80	5.78	5.84	5.21	5.35	5.47	5.44	5.17
Fixed Asset Turnover	7.93	7.96	7.88	7.83	7.72	7.61	7.75	7.90	7.89	8.10
Accounts Payable Turnover	7.75	8.34	8.20	9.09	9.01	8.69	8.37	9.39	9.19	9.25
Days Sales Outstanding (DSO)	2.53	2.65	3.32	2.56	2.74	2.86	3.29	2.62	3.18	2.81
Days Inventory Outstanding (DIO)	64.39	66.52	62.98	63.12	62.54	70.10	68.19	66.73	67.13	70.58
Days Payable Outstanding (DPO)	47.07	43.75	44.49	40.16	40.53	42.02	43.60	38.88	39.71	39.46
Cash Conversion Cycle (CCC)	19.85	25.41	21.80	25.52	24.75	30.95	27.88	30.47	30.61	33.92
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,531	2,588	2,585	2,651	2,651	2,633	3,835	3,870	3,831	3,833
Invested Capital Turnover	2.36	2.39	1.94	1.91	1.93	1.90	1.40	1.60	1.85	1.59
Increase / (Decrease) in Invested Capital	-120	-45	-1,251	-1,219	-1,180	-1,200	-1,111	114	1,149	170
Enterprise Value (EV)	2,490	2,867	2,354	1,965	2,226	2,445	3,947	4,502	5,015	4,728
Market Capitalization	1,072	1,402	901	476	760	1,005	2,527	3,033	3,566	3,223
Book Value per Share	$3.55	$3.60	$3.64	$3.78	$3.87	$3.90	$7.92	$7.88	$7.84	$7.67
Tangible Book Value per Share	($2.84)	($2.83)	($2.81)	($2.74)	($2.68)	($2.65)	($2.65)	($2.69)	($2.76)	($2.93)
Total Capital	2,697	2,705	2,712	2,740	2,777	2,773	4,008	4,019	4,033	3,982
Total Debt	1,583	1,582	1,581	1,578	1,592	1,580	1,594	1,618	1,651	1,654
Total Long-Term Debt	1,578	1,577	1,576	1,574	1,576	1,575	1,589	1,612	1,628	1,631
Net Debt	1,418	1,465	1,453	1,488	1,467	1,440	1,421	1,469	1,449	1,505
Capital Expenditures (CapEx)	37	31	27	33	49	63	52	62	66	76
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-326	-293	-298	-251	-271	-242	-218	-163	-184	-164
Debt-free Net Working Capital (DFNWC)	-160	-177	-171	-162	-145	-102	-45	-14	18	-16
Net Working Capital (NWC)	-166	-182	-176	-165	-161	-107	-50	-20	-5.26	-38
Net Nonoperating Expense (NNE)	26	19	27	35	23	379	31	21	18	19
Net Nonoperating Obligations (NNO)	1,418	1,465	1,453	1,488	1,467	1,440	1,421	1,469	1,449	1,505
Total Depreciation and Amortization (D&A)	52	51	51	51	54	52	50	50	51	49
Debt-free, Cash-free Net Working Capital to Revenue	-5.33%	-4.70%	-4.80%	-4.04%	-4.33%	-3.93%	-3.54%	-2.67%	-3.05%	-2.75%
Debt-free Net Working Capital to Revenue	-2.62%	-2.83%	-2.75%	-2.60%	-2.33%	-1.66%	-0.73%	-0.23%	0.29%	-0.26%
Net Working Capital to Revenue	-2.71%	-2.92%	-2.83%	-2.66%	-2.58%	-1.74%	-0.81%	-0.33%	-0.09%	-0.64%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.05)	($0.06)	($0.09)	($0.17)	($0.09)	($4.63)	($0.05)	($0.01)	$0.13	$0.07
Adjusted Weighted Average Basic Shares Outstanding	273.41M	274.50M	273.07M	269.77M	267.55M	267.85M	267.16M	266.49M	265.52M	265.69M
Adjusted Diluted Earnings per Share	($0.05)	($0.06)	($0.09)	($0.17)	($0.09)	($4.63)	($0.05)	($0.01)	$0.13	$0.07
Adjusted Weighted Average Diluted Shares Outstanding	273.41M	274.50M	273.07M	269.77M	267.55M	267.85M	267.16M	266.49M	265.95M	265.94M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	315.13M	313.45M	312.15M	310.78M	307.37M	306.28M	305.56M	304.80M	304.55M	303.71M
Normalized Net Operating Profit after Tax (NOPAT)	12	2.78	1.73	-12	0.12	-6.73	17	19	51	39
Normalized NOPAT Margin	0.78%	0.18%	0.11%	-0.77%	0.01%	-0.45%	1.10%	1.24%	3.22%	2.58%
Pre Tax Income Margin	-1.06%	-1.46%	-2.21%	-3.65%	-2.34%	-84.84%	-0.73%	-0.39%	2.67%	1.43%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.48	0.35	0.07	-0.53	0.00	-33.54	0.68	0.81	2.26	1.78
NOPAT to Interest Expense	0.36	0.08	0.05	-0.32	0.00	-23.48	0.45	0.51	1.54	1.42
EBIT Less CapEx to Interest Expense	-0.60	-0.51	-0.68	-1.41	-1.23	-35.24	-0.69	-0.84	0.26	-1.00
NOPAT Less CapEx to Interest Expense	-0.72	-0.78	-0.70	-1.21	-1.23	-25.18	-0.93	-1.13	-0.46	-1.36
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Petco Health and Wellness' Financials

When does Petco Health and Wellness's fiscal year end?

According to the most recent income statement we have on file, Petco Health and Wellness' financial year ends in February. Their financial year 2025 ended on February 1, 2025.

How has Petco Health and Wellness' net income changed over the last 5 years?

Petco Health and Wellness' net income appears to be on an upward trend, with a most recent value of -$101.82 million in 2024, falling from -$103.98 million in 2019. The previous period was -$1.28 billion in 2023. View Petco Health and Wellness' forecast to see where analysts expect Petco Health and Wellness to go next.

What is Petco Health and Wellness's operating income?

Petco Health and Wellness's total operating income in 2024 was $7.05 million, based on the following breakdown:

Total Gross Profit: $2.32 billion
Total Operating Expenses: $2.32 billion

How has Petco Health and Wellness revenue changed over the last 5 years?

Over the last 5 years, Petco Health and Wellness' total revenue changed from $4.43 billion in 2019 to $6.12 billion in 2024, a change of 37.9%.

How much debt does Petco Health and Wellness have?

Petco Health and Wellness' total liabilities were at $4.08 billion at the end of 2024, a 2.3% decrease from 2023, and a 1.5% increase since 2020.

How much cash does Petco Health and Wellness have?

In the past 4 years, Petco Health and Wellness' cash and equivalents has ranged from $111.40 million in 2020 to $211.60 million in 2021, and is currently $165.76 million as of their latest financial filing in 2024.

How has Petco Health and Wellness' book value per share changed over the last 5 years?

Over the last 5 years, Petco Health and Wellness' book value per share changed from 0.00 in 2019 to 3.55 in 2024, a change of 355.3%.

Related Companies

This page (NASDAQ:WOOF) was last updated on 6/1/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Petco Health and Wellness (WOOF) Financials

Frequently Asked Questions About Petco Health and Wellness' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Petco Health and Wellness (WOOF) Financials

Annual Income Statements for Petco Health and Wellness

Quarterly Income Statements for Petco Health and Wellness

Annual Cash Flow Statements for Petco Health and Wellness

Quarterly Cash Flow Statements for Petco Health and Wellness

Annual Balance Sheets for Petco Health and Wellness

Quarterly Balance Sheets for Petco Health and Wellness

Annual Metrics And Ratios for Petco Health and Wellness

Quarterly Metrics And Ratios for Petco Health and Wellness

Frequently Asked Questions About Petco Health and Wellness' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools